BioSpace News Archive

Drug Development

Aeromics Initiates Phase 1 Clinical Trial of CNS Edema Inhibitor AER-271 In Healthy Human Volunteers

Aeromics is conducting a double-blind, randomized, placebo-controlled Phase 1 clinical trial with their intravenously (IV) administered prodrug AER-271 which is designed to deliver therapeutically effective concentrations of the active component AER-270.

July 9, 2018
·
3 min read
Business

The American Health Council Welcomes Daniel Lichtstein, MD to Board of Physicians

Dr. Lichtstein is responsible for the oversight of all undergraduate and graduate medical education activities on the regional campus.

July 9, 2018
·
3 min read
NobleStitch™ EL PFO Closure Performed Live For TVT/ PFO 2018 Congress

NOBLESTITCH™ PFO CLOSURE SYSTEM PRESENTED LIVE FOR THE FIRST TIME

July 9, 2018
·
6 min read
Business

DarioHealth Appoints Healthcare Technology Entrepreneur and Venture Capital Partner Yoav Shaked as Chairman of the Board

DarioHealth Corp. announced Yoav Shaked has joined the Company as Chairman of the Board.

July 9, 2018
·
4 min read
Pharm Country

HSS Researchers Launch Study to Look for Clues to Meniscal Healing After Surgery

Researchers at Hospital for Special Surgery in New York City are launching a new study to identify inflammatory molecules that might help improve treatment of people with certain knee injuries.

July 9, 2018
·
6 min read
Business

Tocagen Closes Previously Announced License Agreement with ApolloBio to Develop and Commercialize Toca 511 & Toca FC in Greater China

Tocagen Inc. and Beijing Apollo Venus Biomedical Technology Limited announced the closing of an agreement providing ApolloBio with the exclusive right to develop and commercialize Toca 511 & Toca FC within the greater China region.

July 9, 2018
·
6 min read
Deals

MabVax Therapeutics and Boehringer Ingelheim Sign Asset Purchase and License Agreement and Related Agreements for an Antibody Development Program Targeting Multiple Solid Tumor Cancers

MabVax Therapeutics Holdings, Inc. announced they have signed an asset acquisition and related agreements centered on MabVax’s program targeting a glycan commonly overexpressed on multiple solid tumor cancers. Boehringer Ingelheim has acquired all rights in and to the program.

July 9, 2018
·
5 min read
Deals

BioIVT Acquires Optivia Biotechnology, Adding Transporter Assay Products and Services to its ADME-Tox Portfolio

Acquisition strengthens BioIVT’s transporter sciences capabilities and enables it to partner with customers on new drug applications and mechanistic studies related to transporters.

July 9, 2018
·
4 min read
Drug Development

Citius Provides Clinical Update And Progress Of The Mino-Lok® Phase 3 Trial

PIVOTAL TRIAL ASSESSES THE EFFECTIVENESS AND SAFETY OF MINO-LOK IN THE TREATMENT OF INDIVIDUALS WITH CATHETER RELATED BLOOD STREAM INFECTIONS (CRBSIs)

July 9, 2018
·
6 min read
Business

Myomo Appoints Micah Mitchell as Chief Commercial Officer

Myomo, Inc. announced today that Micah Mitchell is joining the company as chief commercial officer (CCO), a newly created executive role.

July 9, 2018
·
4 min read